BVX — Bivictrix Therapeutics Share News
0.000.00%
- £10.73m
- £7.71m
REG - BiVictriX Therapcts. - Compelling Safety Profile of BVX001
AnnouncementREG - BiVictriX Therapcts. - Innovate UK Grant Award to Accelerate ADC Pipeline
AnnouncementREG - BiVictriX Therapcts. - BiVictriX – Full Year Results 2023
AnnouncementREG - BiVictriX Therapcts. - Orphan Drug Designation & FDA INTERACT Meeting
AnnouncementREG - BiVictriX Therapcts. - Grant of Options – PDMR/Director Dealings
AnnouncementREG - BiVictriX Therapcts. - Holding(s) in Company
AnnouncementREG - BiVictriX Therapcts. - Holding(s) in Company
AnnouncementREG - BiVictriX Therapcts. - BiVictriX Hosts Inaugural Roundtable Discussion
AnnouncementREG - BiVictriX Therapcts. - Board Change
AnnouncementREG - BiVictriX Therapcts. - Pipeline update on BVX002
AnnouncementREG - BiVictriX Therapcts. - Holding(s) in Company
AnnouncementREG - BiVictriX Therapcts. - Patent Granted in Japan
AnnouncementREG - BiVictriX Therapcts. - Extended Survival Rates Reported with BVX001
AnnouncementREG - BiVictriX Therapcts. - Appointment of Adrian Howd as CFO and CBO
AnnouncementREG - BiVictriX Therapcts. - Interim Results
AnnouncementREG - BiVictriX Therapcts. - Total Voting Rights
AnnouncementREG - BiVictriX Therapcts. - US Patent Granted
AnnouncementREG - BiVictriX Therapcts. - Holding(s) in Company
AnnouncementREG - BiVictriX Therapcts. - Holding(s) in Company
Announcement